Role of Nitric Oxide in the Modulation of Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
521-530
Author(s):
Lucia Morbidelli, Sandra Donnini and Marina Ziche
Thrombospondins as Anti-Angiogenic Therapeutic Agents
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
583-588
Author(s):
Bruno Vailhé and Jean-Jacques Feige
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen
Cancer and Phase II Drug-Metabolizing Enzymes
Journal:
Current Drug Metabolism
Volume:
4
Page:
45-58
Author(s):
S. A. Sheweita and A. K. Tilmisany
Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Journal:
Current Pharmaceutical Biotechnology
Volume:
4
Page:
21-37
Author(s):
C. Ivorra, H. Samyn, M. D. Edo, C. Castro, S. M. Sanz-González, A. Diez-Juan and V. Andres
Suicide Gene Therapy Mediated by the Herpes Simplex Virus Thymidine Kinase Gene / Ganciclovir System: Fifteen Years of Application
Journal:
Current Gene Therapy
Volume:
3
Page:
13-26
Author(s):
C. Fillat, M. Carrio, A. Cascante and B. Sangro
Application of In Vivo Electroporation to Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
3
Page:
59-64
Author(s):
Takahiko Tamura and Tsuneaki Sakata
Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Journal:
Current Drug Targets
Volume:
3
Page:
465-482
Author(s):
J.E. Trosko and R.J. Ruch
Cytokines and their Antagonists as Therapeutic Agents
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
2201-2207
Author(s):
Liljana Stevceva